Product Name

Organization name

URL

Profile

Scottish Biomedical is a preclinical drug discovery services company located on the West of Scotland Science Park in Glasgow, Scotland.

Established in 1994, Scottish Biomedical is a private, profitable, self-funded organization with 58 researchers. In addition to the company´s capabilities and expertise in the area of ethical human tissue acquisition, molecular biology and protein technology, Scottish Biomedical´s strengths also include primary & secondary assay development, high-throughput & high-content screening, medicinal chemistry and pharmacology.

By integrating expertise in cell systems biology with medicinal chemistry, Scottish Biomedical has been able to establish many successful drug discovery collaborations with pharmaceutical/biotech clients around the world. 

Today, through collaborations and internal efforts, 2 of the programmes that Scottish Biomedical has worked on have reached Phase II, and a further 2 programmes are currently in Phase I.

In addition to these programmes, Scottish Biomedical currently has over 12 programmes at various stages of pre-clinical development. 

Scottish Biomedical´s collaborations include:

• Ethical acquisition of normal and diseased human tissue
• Identification and validation of new disease targets through genomics & proteomics
• Assay development & HTS
• Discovery and optimization of small molecule lead compounds
• Screening our Lead Generation Library/Focused Libraries
• Rapid SAR & pharmacophore development
• Ex vivo (human tissue), in vitro and in vivo (small animal) Pharmacology & ADME studies

One key feature of all of Scottish Biomedical´s drug discovery collaborations is:  

All of the IP generated is owned by Scottish Biomedical´s clients.

Internal Research Programmes

Scottish Biomedical also has a number of internal research programmes across a range of therapeutic areas that are available for co-development or purchase. Further details are available upon request.

back